333 related articles for article (PubMed ID: 33140403)
1. Safety and efficacy of midazolam nasal spray for the treatment of intermittent bouts of increased seizure activity in the epilepsy monitoring unit: A double-blind, randomized, placebo-controlled trial.
Spencer DC; Sinha SR; Choi EJ; Cleveland JM; King A; Meng TC; Pullman WE; Sequeira DJ; Van Ess PJ; Wheless JW
Epilepsia; 2020 Nov; 61(11):2415-2425. PubMed ID: 33140403
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of midazolam nasal spray in the outpatient treatment of patients with seizure clusters-a randomized, double-blind, placebo-controlled trial.
Detyniecki K; Van Ess PJ; Sequeira DJ; Wheless JW; Meng TC; Pullman WE
Epilepsia; 2019 Sep; 60(9):1797-1808. PubMed ID: 31140596
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of midazolam nasal spray in the outpatient treatment of patients with seizure clusters: An open-label extension trial.
Wheless JW; Meng TC; Van Ess PJ; Detyniecki K; Sequeira DJ; Pullman WE
Epilepsia; 2019 Sep; 60(9):1809-1819. PubMed ID: 31353457
[TBL] [Abstract][Full Text] [Related]
4. Efficacy, Tolerability, and Safety of Concentrated Intranasal Midazolam Spray as Emergency Medication in Epilepsy Patients During Video-EEG Monitoring.
von Blomberg A; Kay L; Knake S; Fuest S; Zöllner JP; Reif PS; Herrmann E; Balaban Ü; Schubert-Bast S; Rosenow F; Strzelczyk A
CNS Drugs; 2020 May; 34(5):545-553. PubMed ID: 32219682
[TBL] [Abstract][Full Text] [Related]
5. Psychosocial outcomes of repeated treatment of seizure clusters with midazolam nasal spray: Results of a phase 3, open-label extension trial.
Meng TC; Szaflarski JP; Chen L; Brunnert M; Campos R; Van Ess P; Pullman WE; Fakhoury T
Epilepsy Behav; 2023 Jan; 138():108989. PubMed ID: 36410152
[TBL] [Abstract][Full Text] [Related]
6. Intranasal midazolam during presurgical epilepsy monitoring is well tolerated, delays seizure recurrence, and protects from generalized tonic-clonic seizures.
Kay L; Reif PS; Belke M; Bauer S; Fründ D; Knake S; Rosenow F; Strzelczyk A
Epilepsia; 2015 Sep; 56(9):1408-14. PubMed ID: 26216711
[TBL] [Abstract][Full Text] [Related]
7. Randomized open-label trial of intravenous brivaracetam versus lorazepam for acute treatment of increased seizure activity.
Szaflarski JP; Sadek A; Greve B; Williams P; Varner JA; Moseley BD
Epilepsy Behav; 2020 Aug; 109():107127. PubMed ID: 32417382
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics, pharmacodynamics, and safety of USL261, a midazolam formulation optimized for intranasal delivery, in a randomized study with healthy volunteers.
Bancke LL; Dworak HA; Rodvold KA; Halvorsen MB; Gidal BE
Epilepsia; 2015 Nov; 56(11):1723-31. PubMed ID: 26332539
[TBL] [Abstract][Full Text] [Related]
9. A critical evaluation of midazolam nasal spray for the treatment of patients with seizure clusters.
Wheless JW
Expert Rev Neurother; 2021 Nov; 21(11):1195-1205. PubMed ID: 33593228
[No Abstract] [Full Text] [Related]
10. Final results from a Phase 3, long-term, open-label, repeat-dose safety study of diazepam nasal spray for seizure clusters in patients with epilepsy.
Wheless JW; Miller I; Hogan RE; Dlugos D; Biton V; Cascino GD; Sperling MR; Liow K; Vazquez B; Segal EB; Tarquinio D; Mauney W; Desai J; Rabinowicz AL; Carrazana E;
Epilepsia; 2021 Oct; 62(10):2485-2495. PubMed ID: 34418086
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of diazepam nasal spray in patients with epilepsy concomitantly using maintenance benzodiazepines: An interim subgroup analysis from a phase 3, long-term, open-label safety study.
Segal EB; Tarquinio D; Miller I; Wheless JW; Dlugos D; Biton V; Cascino GD; Desai J; Hogan RE; Liow K; Sperling MR; Vazquez B; Cook DF; Rabinowicz AL; Carrazana E;
Epilepsia; 2021 Jun; 62(6):1442-1450. PubMed ID: 33942315
[TBL] [Abstract][Full Text] [Related]
12. A double-blind, randomized, placebo-controlled trial of a diazepam auto-injector administered by caregivers to patients with epilepsy who require intermittent intervention for acute repetitive seizures.
Abou-Khalil B; Wheless J; Rogin J; Wolter KD; Pixton GC; Shukla RB; Sherman NA; Sommerville K; Goli V; Roland CL
Epilepsia; 2013 Nov; 54(11):1968-76. PubMed ID: 24111974
[TBL] [Abstract][Full Text] [Related]
13. Comparison of intranasal midazolam versus intravenous lorazepam for seizure termination and prevention of seizure clusters in the adult epilepsy monitoring unit.
Owusu KA; Dhakar MB; Bautista C; McKimmy D; Cotugno S; Sukumar N; Deng Y; Farooque P; Hirsch LJ; Maciel CB
Epilepsy Behav; 2019 Sep; 98(Pt A):161-167. PubMed ID: 31374472
[TBL] [Abstract][Full Text] [Related]
14. Safety of Diazepam Nasal Spray in Children and Adolescents With Epilepsy: Results From a Long-Term Phase 3 Safety Study.
Tarquinio D; Dlugos D; Wheless JW; Desai J; Carrazana E; Rabinowicz AL
Pediatr Neurol; 2022 Jul; 132():50-55. PubMed ID: 35636283
[TBL] [Abstract][Full Text] [Related]
15. The Evaluation of the Efficacy and Safety of Midazolam Nasal Spray in Patients With Seizure Clusters: A Systematic Review and Meta-Analysis.
Niraj N; Mahajan S; Prakash A; Sarma P; Medhi B
Cureus; 2023 Jan; 15(1):e34064. PubMed ID: 36843713
[TBL] [Abstract][Full Text] [Related]
16. Long-term safety and efficacy of lacosamide and controlled-release carbamazepine monotherapy in patients with newly diagnosed epilepsy.
Ben-Menachem E; Grebe HP; Terada K; Jensen L; Li T; De Backer M; Steiniger-Brach B; Gasalla T; Brock M; Biton V
Epilepsia; 2019 Dec; 60(12):2437-2447. PubMed ID: 31755090
[TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacokinetic and pharmacodynamic profile of midazolam nasal spray.
Bouw MR; Chung SS; Gidal B; King A; Tomasovic J; Wheless JW; Van Ess PJ
Epilepsy Res; 2021 Mar; 171():106567. PubMed ID: 33607532
[TBL] [Abstract][Full Text] [Related]
18. Efficacy, safety, and tolerability of adjunctive perampanel in patients from China with focal seizures or generalized tonic-clonic seizures: Post hoc analysis of phase III double-blind and open-label extension studies.
Weiping L; Dong Z; Zhen H; Patten A; Dash A; Malhotra M
CNS Neurosci Ther; 2021 Mar; 27(3):330-340. PubMed ID: 33340263
[TBL] [Abstract][Full Text] [Related]
19. Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus.
Claassen J; Hirsch LJ; Emerson RG; Bates JE; Thompson TB; Mayer SA
Neurology; 2001 Sep; 57(6):1036-42. PubMed ID: 11571331
[TBL] [Abstract][Full Text] [Related]
20. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial.
Biton V; Berkovic SF; Abou-Khalil B; Sperling MR; Johnson ME; Lu S
Epilepsia; 2014 Jan; 55(1):57-66. PubMed ID: 24446953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
